Generics UK

Generics (UK) Limited, commonly known as Generics UK, is a leading pharmaceutical company in the United Kingdom and a key subsidiary of Viatris. The company specializes in the development, manufacture, and distribution of a vast portfolio of high-quality generic and biosimilar medicines, serving as a major supplier to the National Health Service (NHS). Originally an independent entity, it was acquired by Mylan in 2007 and subsequently became part of Viatris following the 2020 merger of Mylan and Pfizer's Upjohn division. Generics UK provides affordable treatment options across numerous therapeutic areas, including cardiovascular health, oncology, and neurology, playing a vital role in the UK's healthcare infrastructure. The company is also recognized for its active participation in patent litigation and competition law cases aimed at facilitating generic entry into the UK market.